Astemax Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 14.50%
- Profit Growth 0.78%
- Ebitda 5.66%
- Net Worth 45.44%
- Total Assets 188.36%
About Astemax Biotech
Astemax Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 July 2011 and has a history of 13 years and six months. Its registered office is in Karnal, Haryana, India.
The Corporate was formerly known as Astellas Biotech Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Devi Dyal and Rahul Choudhary serve as directors at the Company.
Company Details
-
Location
Karnal, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100HR2011PTC043480
-
Company No.
043480
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jul 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Astemax Biotech Private Limited offer?
Astemax Biotech Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cardiovascular Drugs & Medication, Kidney Drugs, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Who are the key members and board of directors at Astemax Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devi Dyal
|
Director | 01-Apr-2019 | Current |
|
Rahul Choudhary
|
Director | 21-Feb-2022 | Current |
Financial Performance of Astemax Biotech.
Astemax Biotech Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 14.5% increase. The company also saw a slight improvement in profitability, with a 0.78% increase in profit. The company's net worth Soared by an impressive increase of 45.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astemax Biotech?
In 2017, Astemax Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Atlina Lifesciences Private LimitedDevi Dyal is a mutual person
-
Benefast Biotech Private LimitedDevi Dyal is a mutual person
-
Essendon Formulations Private Limited
Devi Dyal and Rahul Choudhary are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Astemax Biotech?
Unlock and access historical data on people associated with Astemax Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astemax Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astemax Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
